OSL Corpse, page-22

Ok, so the SP has flatlined despite CE, we now say new positive inflection point is sales.
Why have there been no sales? They’ve been approved for sale for over 4 months now in Europe. In fact I’d be sure they’d have had plenty of notice CE was coming well before announcing to market on 1st April. Yes yes we know there’s Covid and that’s a disruptor but that wouldn’t have magically stopped LAPC cases. They worked with some respected hospitals on the trial in UK eg London, Cambridge so have existing relationships with oncologists and people there who know and can use device. So why no sales? Not even one in over 4 months ? Not one private pay patient desperately looking for an option??

i hope a face 2 face (socially distanced) AGM does take place because the company has dodged investor questions for a very long time!